Similar Papers

Paper Title
Journal
Date
Author
Author response: Targeting the fatty acid binding proteins disrupts multiple myeloma cell cycle progression and MYC signaling
Mariah Farrell ... Carolyne Falank
-
Mariah Farrell, et. al.Mariah Farrell ... Carolyne Falank
01 Feb 2023
Fatty acid binding protein (FABP) inhibitors: a patent review (2012-2015)
Yan-Ting Wang ... Hai-Liang Zhu
Expert Opinion on Therapeutic Patents | VOL. 26
Yan-Ting Wang, et. al.Yan-Ting Wang ... Hai-Liang Zhu
10 May 2016
Fatty acid-binding protein 4 is a therapeutic target for septic acute kidney injury by regulating inflammatory response and cell apoptosis
Bo Wang ... Liang Ma
Cell death & disease | VOL. 13
Bo Wang, et. al.Bo Wang ... Liang Ma
01 Apr 2022
Fatty Acid-Binding Protein 4 in Endometrial Epithelium Is Involved in Embryonic Implantation
Peng Wang ... Qiuyuan Zhu
Cellular Physiology and Biochemistry | VOL. 41
Peng Wang, et. al.Peng Wang ... Qiuyuan Zhu
01 Jan 2017
View more papers

More From: Journal of the American Society of Nephrology

Paper Title
Journal
Date
Author
A Roadmap for Disaster Risk Reduction and Management in Kidney Care
Shaifali Sandal ... Caroline Stigant
Journal of the American Society of Nephrology | VOL. -
Shaifali Sandal, et. al.Shaifali Sandal ... Caroline Stigant
06 Feb 2025
Effects of Clazakizumab on Anemia and Iron Metabolism in Patients with Kidney Failure
Brendon L Neuen ... Glenn M Chertow
Journal of the American Society of Nephrology | VOL. -
Brendon L Neuen, et. al.Brendon L Neuen ... Glenn M Chertow
05 Feb 2025
Genotype-Based Molecular Mechanisms in Alport Syndrome
Emine Bilge Caparali ... Moumita Barua
Journal of the American Society of Nephrology | VOL. -
Emine Bilge Caparali, et. al.Emine Bilge Caparali ... Moumita Barua
03 Feb 2025
Cover Image
Goran Stanajic-Petrovic ... Nicolas Gilles
Journal of the American Society of Nephrology | VOL. 36
Goran Stanajic-Petrovic, et. al.Goran Stanajic-Petrovic ... Nicolas Gilles
01 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.